Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of <i>MYC</i> paralogs

Shreoshi Pal Choudhuri(Southwestern Medical Center), Benjamin J. Drapkin(Southwestern Medical Center)
bioRxiv (Cold Spring Harbor Laboratory)
June 26, 2023
10.1101/2023.06.23.546278
Cited by 6

Related Papers

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
|British Journal of Pharmacology|2021|275
Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
|Cell|2019|260
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
|Cancer Discovery|2019|238
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
|Cancer Discovery|2018|216
The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets
|British Journal of Pharmacology|2023|215